Novartis receives European Commission approval for Rhapsido skin disease drug - Reuters

Reuters | April 27, 2026, 1:31 a.m. | Original
Novartis receives European Commission approval for Rhapsido skin disease drug Reuters
Germany's Nordex posts strong quarterly profit on European wind demand - Reuters Exosens' sales surge 20% as demand for drone tech booms - Reuters